Mackenzie Financial’s BeOne Medicines Ltd ONC Stock Holding History

Mackenzie Financial’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.22M	Buy	7,786 +1,705	+28%	+$502K	﹤0.01%	1027
2026 Q1	$1.81M	Sell	6,081 -24,778	-80%	-$8.02M	﹤0.01%	948
2025 Q4	$9.38M	Sell	30,859 -5,237	-15%	-$1.71M	0.01%	520
2025 Q3	$12.3M	Sell	36,096 -5,232	-13%	-$1.59M	0.01%	464
2025 Q2	$10M	Buy	41,328 +1,073	+3%	+$263K	0.01%	481
2025 Q1	$11M	Buy	40,255 +19,665	+96%	+$4.6M	0.02%	445
2024 Q4	$3.8M	Sell	20,590 -22,605	-52%	-$4.62M	0.01%	623
2024 Q3	$9.7M	Buy	+43,195	New	+$7.77M	0.01%	449
2019 Q2	–	Sell	-3,432	Closed	-$453K	–	1279
2019 Q1	$453K	Sell	3,432 -114	-3%	-$15.4K	﹤0.01%	1042
2018 Q4	$497K	Buy	+3,546	New	+$470K	﹤0.01%	936
2018 Q2	–	Sell	-3,944	Closed	-$663K	–	1063
2018 Q1	$663K	Buy	3,944 +1,381	+54%	+$187K	﹤0.01%	690
2017 Q4	$250K	Buy	+2,563	New	+$235K	﹤0.01%	778

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mackenzie Financial's ONC Position: Q2 2026 in Review

Mackenzie Financial increased its BeOne Medicines Ltd (ONC) stake by 28% in Q2 2026, buying an estimated $502K and bringing the position to 7,786 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

Mackenzie Financial first reported a position in ONC in Q4 2017 and has held it in 12 quarters since. The position peaked at $12.3M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Mackenzie Financial held 7,786 shares of BeOne Medicines Ltd worth $2.22M as of Q2 2026.
Mackenzie Financial bought 1,705 BeOne Medicines Ltd shares in Q2 2026, an estimated $502K.
BeOne Medicines Ltd made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1027 holding.
Mackenzie Financial first reported a position in BeOne Medicines Ltd in Q4 2017 and has held it in 12 quarters since.
Mackenzie Financial's BeOne Medicines Ltd position peaked at $12.3M in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.